EW vs ISPC · P/E 47, rev $1.39B vs rev $9.3M
Edwards Lifesciences Corp (EW) versus iSpecimen Inc (ISPC) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
iSpecimen Inc (ISPC) is a diagnostics & research company listed on US.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported ISPC revenue for 2024-12-31 was $9.3M. Net income was -$12.5M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ISPC currently screens at market cap $4.4M.
EW currently screens at market cap $49.91B and trailing P/E 46.9. ISPC currently screens at market cap $4.4M.
Not investment advice. Open the EW and ISPC stock pages for the full models.
Not investment advice.